CLC number:
On-line Access: 2023-06-13
Received: 2022-12-11
Revision Accepted: 2023-02-27
Crosschecked: 2023-07-21
Cited: 0
Clicked: 749
Citations: Bibtex RefMan EndNote GB/T7714
Mingtao LIU, Jiali LYU, Xianhui ZHENG, Zhiman LIANG, Baoying LEI, Huihuang CHEN, Yiyin MAI, Huimin HUANG, Baoqing SUN. Evolution of the newest diagnostic methods for COVID-19: a Chinese perspective[J]. Journal of Zhejiang University Science B,in press.Frontiers of Information Technology & Electronic Engineering,in press.https://doi.org/10.1631/jzus.B2200625 @article{title="Evolution of the newest diagnostic methods for COVID-19: a Chinese perspective", %0 Journal Article TY - JOUR
中国视角下的新冠肺炎最新诊断方法演进1广州医科大学附属第一医院, 广州呼吸健康研究院, 呼吸疾病国家重点实验室, 国家呼吸疾病临床医学中心, 国家呼吸医学中心, 检验科, 中国广州市, 510140 2广州医科大学附属第一医院, 广州呼吸健康研究院, 呼吸疾病国家重点实验室, 国家呼吸疾病临床医学中心, 国家呼吸医学中心, 中国广州市, 510140 3广州医科大学, 中国广州市, 511495 摘要: 自2019年底以来,新型冠状病毒感染(COVID-19)继续在全球蔓延,对世界卫生保健系统构成严峻挑战,造成严重破坏,并通过人类接触迅速传播。这种疾病的主要症状是发烧、疲劳和持续的干咳,它威胁到我们全球社会健康系统的平衡。快速准确诊断新冠肺炎是掌握全球或地区确诊病例数量的前提,也是疫情评估和制定控制措施的重要因素。同时,这也确保患者获得合理治疗,为患者获得最佳的护理方案发挥着至关重要的作用。逆转录聚合酶链反应(RT-PCR)技术是目前检测病毒核酸最成熟的方法,但它存在很多缺点。与此同时,分子生物学诊断、免疫诊断、影像学、人工智能等多种新型冠状病毒检测方法已经开发并应用于临床,适应不同场景和需求。这些方法可以帮助临床医生诊断和治疗COVID-19患者。本文总结了目前国内常用于新冠肺炎诊断的多种最新检测方法,为新冠肺炎临床诊断提供了重要参考。 关键词: SARS-CoV-2;COVID-19;诊断;聚合酶链式反应(PCR);免疫分析;影像学 Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article
Reference[1]AdamsSH, ParkMJ, SchaubJP, et al., 2020. Medical vulnerability of young adults to severe COVID-19 illness—data from the national health interview survey. J Adolesc Health, 67(3):362-368. [2]AlqahtaniMS, AbbasM, AlqahtaniA, et al., 2021. A novel computational model for detecting the severity of inflammation in confirmed COVID-19 patients using chest X-ray images. Diagnostics (Basel), 11(5):855. [3]Al-TawfiqJA, 2020. Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19). Travel Med Infect Dis, 35:101608. [4]BaiHX, HsiehB, XiongZ, et al., 2020. Performance of radiologists in differentiating COVID-19 from non-COVID-19 viral pneumonia at chest CT. Radiology, 296(2):E46-E54. [5]BaiY, TaoXN, 2021. Comparison of COVID-19 and influenza characteristics. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 22(2):87-98. [6]BalA, DestrasG, GaymardA, et al., 2020. Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del). Clin Microbiol Infect, 26(7):960-962. [7]BernheimA, MeiXY, HuangMQ, et al., 2020. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology, 295(3):685-691. [8]BeyerlJ, Rubio-AceroR, CastellettiN, et al., 2021. A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay. eBioMedicine, 70:103502. [9]BourassaL, PerchettiGA, PhungQ, et al., 2021. A SARS-CoV-2 nucleocapsid variant that affects antigen test performance. J Clin Virol, 141:104900. [10]BrodinP, 2021. Immune determinants of COVID-19 disease presentation and severity. Nat Med, 27(1):28-33. [11]CaoYL, JianFC, WangJ, et al., 2023. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature, 614(7948):521-529. [12]ChakrabortyS, ChandranD, MohapatraRK, et al., 2022. Langya virus, a newly identified Henipavirus in China‒Zoonotic pathogen causing febrile illness in humans, and its health concerns: current knowledge and counteracting strategies‒Correspondence. Int J Surg, 105:106882. [13]ChanJF, YuanSF, KokKH, et al., 2020. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 395(10223):514-523. [14]ChandranD, DhamaK, ChakrabortyS, et al., 2022. Monkeypox: an update on current knowledge and research advances. J Exp Biol Agric Sci, 10(4):679-688. [15]ChauCH, StropeJD, FiggWD, 2020. COVID-19 clinical diagnostics and testing technology. Pharmacotherapy, 40(8):857-868. [16]ChenXP, HuWJ, YangM, et al., 2021. Risk factors for the delayed viral clearance in COVID-19 patients. J Clin Hypertens (Greenwich), 23(8):1483-1489. [17]ChenYJ, ShiY, ChenY, et al., 2020. Contamination-free visual detection of SARS-CoV-2 with CRISPR/Cas12a: a promising method in the point-of-care detection. Biosens Bioelectron, 169:112642. [18]ChengZJ, ShanJ, 2020. 2019 Novel coronavirus: where we are and what we know. Infection, 48(2):155-163. [19]ChengZJ, ZhanZQ, XueMS, et al., 2023. Public health measures and the control of COVID-19 in China. Clin Rev Allergy Immunol, 64(1):1-16. [20]ConteC, 2021. Possible link between SARS-CoV-2 infection and Parkinson’s disease: the role of Toll-like receptor 4. Int J Mol Sci, 22(13):7135. [21]CormanVM, LandtO, KaiserM, et al., 2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill, 25(3):2000045. [22]CormanVM, HaageVC, BleickerT, et al., 2021. Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study. Lancet Microbe, 2(7):e311-e319. [23]da SilvaSJR, da SilvaCTA, GuarinesKM, et al., 2020. Clinical and laboratory diagnosis of SARS-CoV-2, the virus causing COVID-19. ACS Infect Dis, 6(9):2319-2336. [24]DaiWH, ZhangB, JiangXM, et al., 2020. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science, 368(6497):1331-1335. [25]DhedaK, RuhwaldM, TheronG, et al., 2013. Point-of-care diagnosis of tuberculosis: past, present and future. Respirology, 18(2):217-232. [26]DhochakN, SinghalT, KabraSK, et al., 2020. Pathophysiology of COVID-19: why children fare better than adults? Indian J Pediatr, 87(7):537-546. [27]DouYZ, SuJ, ChenSX, et al., 2022. A smartphone-based three-in-one biosensor for co-detection of SARS-CoV-2 viral RNA, antigen and antibody. Chem Commun, 58(41):6108-6111. [28]FangYC, ZhangHQ, XieJC, et al., 2020. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology, 296(2):E115-E117. [29]FangZF, SunBQ, ZhuAR, et al., 2021. Multiplexed analysis of circulating IgA antibodies for SARS-CoV-2 and common respiratory pathogens in COVID-19 patients. J Med Virol, 93(5):3257-3260. [30]FitzpatrickMC, PandeyA, WellsCR, et al., 2021. Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests. Lancet, 397(10268):24-25. [31]FrankMG, NguyenKH, BallJB, et al., 2022. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: evidence of PAMP-like properties. Brain Behav Immun, 100:267-277. [32]GaoJW, WangCH, ChuYJ, et al., 2022. Graphene oxide-graphene Van der Waals heterostructure transistor biosensor for SARS-CoV-2 protein detection. Talanta, 240:123197. [33]GaoW, TianJJ, HuangKL, et al., 2019. Ultrafast, universal and visual screening of dual genetically modified elements based on dual super PCR and a lateral flow biosensor. Food Chem, 279:246-251. [34]GaoYP, HuangKJ, WangFT, et al., 2022. Recent advances in biological detection with rolling circle amplification: design strategy, biosensing mechanism, and practical applications. Analyst, 147(15):3396-3414. [35]García-FiñanaM, BuchanIE, 2021. Rapid antigen testing in COVID-19 responses: SARS-CoV-2 transmission was reduced with measures centered on rapid antigen testing. Science, 372(6542):571-572. [36]GauglerS, SottasPE, BlumK, et al, 2021. Fully automated dried blood spot sample handling and extraction for serological testing of SARS-CoV-2 antibodies. Drug Test Anal, 13(1):223-226. [37]GiliA, PaggiR, RussoC, et al., 2021. Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening. Int J Infect Dis, 105:391-396. [38]GillJL, WilliamsJW, JacksonST, et al., 2009. Pleistocene megafaunal collapse, novel plant communities, and enhanced fire regimes in North America. Science, 326(5956):1100-1103. [39]GreenwoodD, RichardS, BarerM, et al., 2012. Medical Microbiology. Elsevier, Amsterdam, The Netherlands. [40]GrubaughND, LadnerJT, LemeyP, et al., 2019. Tracking virus outbreaks in the twenty-first century. Nat Microbiol, 4(1):10-19. [41]GuW, MillerS, ChiuCY, 2019. Clinical metagenomic next-generation sequencing for pathogen detection. Annu Rev Pathol, 14:319-338. [42]GuoM, TaoWY, FlavellRA, et al., 2021. Potential intestinal infection and faecal-oral transmission of SARS-CoV-2. Nat Rev Gastroenterol Hepatol, 18(4):269-283. [43]HarcourtJ, TaminA, LuXY, et al., 2020. Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, United States. Emerg Infect Dis, 26(6):1266-1273. [44]HirotsuY, MaejimaM, ShibusawaM, et al., 2020. Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients. Int J Infect Dis, 99:397-402. [45]HirotsuY, MaejimaM, ShibusawaM, et al., 2021a. Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: comparison with RT-qPCR. Int J Infect Dis, 105:7-14. [46]HirotsuY, SugiuraH, MaejimaM, et al., 2021b. Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19. Int J Infect Dis, 108:263-269. [47]HollandLA, KaelinEA, MaqsoodR, et al., 2020. An 81-nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (January to March 2020). J Virol, 94(14):e00711-20. [48]HuXJ, DengQY, LiJM, et al., 2020. Development and clinical application of a rapid and sensitive loop-mediated isothermal amplification test for SARS-CoV-2 infection. mSphere, 5(4):e00808-20. [49]HuangL, TianSL, ZhaoWH, et al., 2020. Multiplexed detection of biomarkers in lateral-flow immunoassays. Analyst, 145(8):2828-2840. [50]IscoveNN, BarbaraM, GuM, et al., 2002. Representation is faithfully preserved in global cDNA amplified exponentially from sub-picogram quantities of mRNA. Nat Biotechnol, 20(9):940-943. [51]IslamA, SangkhamS, TiwariA, et al., 2022a. Association between global monkeypox cases and meteorological factors. Int J Environ Res Public Health, 19(23):15638. [52]IslamA, HasanMN, AhammedT, et al., 2022b. Association of household fuel with acute respiratory infection (ARI) under-five years children in Bangladesh. Front Public Health, 10:985445. [53]IslamA, HemoMK, ChopraH, et al., 2022c. Old enemy with a new face: re-emerging monkeypox disease-an update. J Pure Appl Microbiol, 16(S1):2972-2988. [54]IslamA, HaqueA, RahmanA, et al., 2022d. A review on measures to rejuvenate immune system: natural mode of protection against coronavirus infection. Front Immunol, 13:837290. [55]IslamA, AhammedT, NoorSTA, 2022e. An estimation of five-decade long monkeypox case fatality rate: systematic review and meta-analysis. J Pure Appl Microbiol, 16(S1):3036-3047. [56]IslamA, RahmanA, JakariyaM, et al., 2023a. A 30-day follow-up study on the prevalence of SARS-CoV-2 genetic markers in wastewater from the residence of COVID-19 patient and comparison with clinical positivity. Sci Total Environ, 858:159350. [57]IslamA, AdeizaSS, AminR, et al., 2023b. A bibliometric study on Marburg virus research with prevention and control strategies. Front Trop Dis, 3:1068364. [58]IslamA, HossenF, RahmanA, et al., 2023c. An opinion on Wastewater-Based Epidemiological Monitoring (WBEM) with Clinical Diagnostic Test (CDT) for detecting high-prevalence areas of community COVID-19 infections. Curr Opin Environ Sci Health, 31:100396. [59]JakariyaM, AhmedF, IslamA, et al., 2022. Wastewater-based epidemiological surveillance to monitor the prevalence of SARS-CoV-2 in developing countries with onsite sanitation facilities. Environ Pollut, 311:119679. [60]KamesJ, HolcombDD, KimchiO, et al., 2020. Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design. Sci Rep, 10:15643. [61]KarpDG, DanhK, EspinozaNF, et al., 2020. A serological assay to detect SARS-CoV-2 antibodies in at-home collected finger-prick dried blood spots. Sci Rep, 10:20188. [62]KobayashiY, MitsudomiT, 2013. Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected? Transl Lung Cancer Res, 2(5):354-363. [63]KoczulaKM, GallottaA, 2016. Lateral flow assays. Essays Biochem, 60(1):111-120. [64]KrüttgenA, CornelissenCG, DreherM, et al., 2021. Comparison of the SARS-CoV-2 rapid antigen test to the real star SARS-CoV-2 RT PCR kit. J Virol Methods, 288:114024. [65]KubinaR, DziedzicA, 2020. Molecular and serological tests for COVID-19. A comparative review of SARS-CoV-2 coronavirus laboratory and point-of-care diagnostics. Diagnostics, 10(6):434. [66]KucirkaLM, LauerSA, LaeyendeckerO, et al., 2020. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann Intern Med, 173(4):262-267. [67]KuntipN, JaprungD, PongprayoonP, 2021. What happens when a complementary DNA meets miR-29a cancer biomarker in complex with a graphene quantum dot. ACS Appl Bio Mater, 4(12):8368-8376. [68]KurhadeC, ZouJ, XiaHJ, et al., 2023. Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster. Nat Med, 29(2):344-347. [69]la MarcaA, CapuzzoM, PagliaT, et al., 2020. Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays. Reprod Biomed Online, 41(3):483-499. [70]LanciottiRS, CalisherCH, GublerDJ, et al., 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol, 30(3):545-551. [71]LeixnerG, Voill-GlaningerA, BonnerE, et al., 2021. Evaluation of the AMP SARS-CoV-2 rapid antigen test in a hospital setting. Int J Infect Dis, 108:353-356. [72]LiF, YeQH, ChenMT, et al., 2021. Cas12aFDet: a CRISPR/Cas12a-based fluorescence platform for sensitive and specific detection of Listeria monocytogenes serotype 4c. Anal Chim Acta, 1151:338248. [73]LiTW, ShaoYF, FuLY, et al., 2018. Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection. J Mol Med, 96(1):85-96. [74]LiYY, YangX, ZhaoWA, 2017. Emerging microtechnologies and automated systems for rapid bacterial identification and antibiotic susceptibility testing. SLAS Technol, 22(6):585-608. [75]LiZT, YiYX, LuoXM, et al., 2020. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol, 92(9):1518-1524. [76]LiuJ, GratzJ, AmourC, et al., 2016. Optimization of quantitative PCR methods for enteropathogen detection. PLoS ONE, 11(6):e0158199. [77]LvDF, YingQM, WengYS, et al., 2020. Dynamic change process of target genes by RT-PCR testing of SARS-CoV-2 during the course of a Coronavirus Disease 2019 patient. Clin Chim Acta, 506:172-175. [78]MackayIM, 2004. Real-time PCR in the microbiology laboratory. Clin Microbiol Infect, 10(3):190-212. [79]MahalakshmiAM, RayB, TuladharS, et al., 2021. Does COVID-19 contribute to development of neurological disease? Immun Inflamm Dis, 9(1):48-58. [80]ManentiA, MaggettiM, CasaE, et al., 2020. Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples. J Med Virol, 92(10):2096-2104. [81]McDadeTW, McNallyEM, ZelikovichAS, et al., 2020. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay. PLoS ONE, 15(8):e0237833. [82]MenchinelliG, BordiL, LiottiFM, et al., 2021. Lumipulse G SARS-CoV-2 Ag assay evaluation using clinical samples from different testing groups. Clin Chem Lab Med, 59(8):1468-1476. [83]MercerTR, SalitM, 2021. Testing at scale during the COVID-19 pandemic. Nat Rev Genet, 22(7):415-426. [84]MetzkerML, 2010. Sequencing technologies—the next generation. Nat Rev Genet, 11(1):31-46. [85]MiessePK, CollierBB, GrantRP, 2022. Monitoring of SARS-CoV-2 antibodies using dried blood spot for at-home collection. Sci Rep, 12:5812. [86]MinaMJ, ParkerR, LarremoreDB, 2020. Rethinking Covid-19 test sensitivity—a strategy for containment. N Engl J Med, 383(22):e120. [87]MohammadiMR, OmidiAH, SabatiH, 2022. Current trends and new methods of detection of SARS-CoV-2 infection. Cell Mol Biomed Rep, 2(3):138-150. [88]MontesinosI, GrusonD, KabambaB, et al., 2020. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. J Clin Virol, 128:104413. [89]MorleyGL, TaylorS, JossiS, et al., 2020. Sensitive detection of SARS-CoV-2-specific antibodies in dried blood spot samples. Emerg Infect Dis, 26(12):2970-2973. [90]MotayoBO, OluwasemowoOO, OlusolaBA, et al., 2021. Evolution and genetic diversity of SARS-CoV-2 in Africa using whole genome sequences. Int J Infect Dis, 103:282-287. [91]MuhiS, TaylerN, HoangT, et al., 2021. Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: a validation and implementation study. Lancet Reg Health West Pac, 9:100115. [92]NicolT, LefeuvreC, SerriO, et al., 2020. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech). J Clin Virol, 129:104511. [93]NieJH, LiQQ, WuJJ, et al., 2020. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg Microbes Infect, 9(1):680-686. [94]OranDP, TopolEJ, 2020. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med, 173(5):362-367. [95]Oude MunninkBB, NieuwenhuijseDF, SteinM, et al., 2020. Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands. Nat Med, 26(9):1405-1410. [96]PanF, YeTH, SunP, et al., 2020. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology, 295(3):715-721. [97]PangB, XuJY, LiuYM, et al., 2020. Isothermal amplification and ambient visualization in a single tube for the detection of SARS-CoV-2 using loop-mediated amplification and CRISPR technology. Anal Chem, 92(24):16204-16212. [98]PeelingRW, OlliaroPL, BoerasDI, et al., 2021. Scaling up COVID-19 rapid antigen tests: promises and challenges. Lancet Infect Dis, 21(9):e290-e295. [99]PetoJ, 2020. Covid-19 mass testing facilities could end the epidemic rapidly. BMJ, 368:m1163. [100]PumfordEA, LuJK, SpaczaiI, et al., 2020. Developments in integrating nucleic acid isothermal amplification and detection systems for point-of-care diagnostics. Biosens Bioelectron, 170:112674. [101]QiuF, WangHJ, ZhangZK, et al., 2020. Laboratory testing techniques for SARS-CoV-2. J Southern Med Univ, 40(2):164-167 (in Chinese). [102]QuailMA, SmithM, CouplandP, et al., 2012. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics, 13:341. [103]RajpalS, LakhyaniN, SinghAK, et al., 2021. Using handpicked features in conjunction with ResNet-50 for improved detection of COVID-19 from chest X-ray images. Chaos Solitons Fractals, 145:110749. [104]RutalaWA, WeberDJ, 2017. Guideline for disinfection and sterilization in healthcare facilities, 2008. Centers for Disease Control and Prevention. https://stacks.cdc.gov/view/cdc/47378 [105]Safiabadi TaliSH, LeBlancJJ, SadiqZ, et al., 2021. Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection. Clin Microbiol Rev, 34(3):e00228-20. [106]SakibMH, NishatAA, IslamMT, et al., 2021. Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2. Comput Biol Med, 136:104759. [107]SandleT, 2013. Sterility, Sterilisation and Sterility Assurance for Pharmaceuticals: Technology, Validation and Current Regulations. Woodhead Publishing Ltd., Oxford, UK. [108]SantiagoI, 2020. Trends and innovations in biosensors for COVID-19 mass testing. ChemBioChem, 21(20):2880-2889. [109]ShenB, ZhengY, ZhangX, et al., 2020. Clinical evaluation of a rapid colloidal gold immunochromatography assay for SARS-CoV-2 IgM/IgG. Am J Transl Res, 12(4):1348-1354. [110]ShiP, DongYQ, YanHC, et al., 2020. Impact of temperature on the dynamics of the COVID-19 outbreak in China. Sci Total Environ, 728:138890. [111]ShiR, ShanC, DuanXM, et al., 2020. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature, 584(7819):120-124. [112]ShuYL, McCauleyJ, 2017. GISAID: global initiative on sharing all influenza data-from vision to reality. Euro Surveill, 22(13):30494. [113]SinghJ, SharmaS, NaraS, 2015. Evaluation of gold nanoparticle based lateral flow assays for diagnosis of enterobacteriaceae members in food and water. Food Chem, 170:470-483. [114]SiroisM, 2014. Laboratory Procedures for Veterinary Technicians, 6th Ed. Elsevier, St. Louis, USA. [115]SmyrlakiI, EkmanM, LentiniA, et al., 2020. Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR. Nat Commun, 11:4812. [116]SoniA, HerbertC, FilippaiosA, et al., 2022. Comparison of rapid antigen tests’ performance between Delta and Omicron variants of SARS-CoV-2: secondary analysis from a serial home self-testing study. Ann Intern Med, 175(12):1685-1692. [117]SotoI, Zamorano-IllanesR, BecerraR, et al., 2023. A new COVID-19 detection method based on CSK/QAM visible light communication and machine learning. Sensors, 23(3):1533. [118]SteinmanJB, LumFM, HoPPK, et al., 2020. Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics. Proc Natl Acad Sci USA, 117(40):24620-24626. [119]SunT, GuanJ, 2020. Novel coronavirus and the central nervous system. Eur J Neurol, 27(9):e52. [120]TaleghaniN, TaghipourF, 2021. Diagnosis of COVID-19 for controlling the pandemic: a review of the state-of-the-art. Biosens Bioelectron, 174:112830. [121]TanCW, ChiaWN, QinXJ, et al., 2020. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction. Nat Biotechnol, 38(9):1073-1078. [122]TsangNNY, SoHC, NgKY, et al., 2021. Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis. Lancet Infect Dis, 21(9):1233-1245. [123]VerkhratskyA, LiQ, MelinoS, et al., 2020. Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases? Biol Direct, 15:28. [124]WangCJ, LiY, PanYC, et al., 2022. Clinical and immune response characteristics among vaccinated persons infected with SARS-CoV-2 delta variant: a retrospective study. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(11):899-914. [125]WangR, QianCY, PangYA, et al., 2021. opvCRISPR: one-pot visual RT-LAMP-CRISPR platform for SARS-CoV-2 detection. Biosens Bioelectron, 172:112766. [126]WangXN, ZhuYS, JiangHW, et al., 2020. Detection methods of SARS-CoV-2. Chem Life, 40(8):1258-1269 (in Chinese). [127]WangYH, DongCJ, HuY, et al., 2020. Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study. Radiology, 296(2):E55-E64. [128]WangYW, MaDD, ZhangGP, et al., 2022. An electrochemical immunosensor based on SPA and rGO-PEI-Ag-Nf for the detection of arsanilic acid. Molecules, 27(1):172. [129]WenJQ, ChengYF, LingRS, et al., 2020. Antibody-dependent enhancement of coronavirus. Int J Infect Dis, 100:483-489. [130]WuF, ZhaoS, YuB, et al., 2020. A new coronavirus associated with human respiratory disease in China. Nature, 579(7798):265-269. [131]WuQ, WuW, ChenFF, et al., 2022. Highly sensitive and selective surface plasmon resonance biosensor for the detection of SARS-CoV-2 spike S1 protein. Analyst, 147(12):2809-2818. [132]XuZ, ShiL, WangYJ, et al., 2020. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 8(4):420-422. [133]YadavS, SadiqueMA, RanjanP, et al., 2021. SERS based lateral flow immunoassay for point-of-care detection of SARS-CoV-2 in clinical samples. ACS Appl Bio Mater, 4(4):2974-2995. [134]YanC, CuiJ, HuangL, et al., 2020. Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay. Clin Microbiol Infect, 26(6):773-779. [135]YanSJ, AhmadKZ, WardenAR, et al., 2021. One-pot pre-coated interface proximity extension assay for ultrasensitive co-detection of anti-SARS-CoV-2 antibodies and viral RNA. Biosens Bioelectron, 193:113535. [136]YangWJ, CaoQQ, QinL, et al., 2020. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. Journal of Infection, 80(4):388-393. [137]YuanSJ, PanY, XiaY, et al., 2021. Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 22(4):318-329. [138]YüceM, FiliztekinE, ÖzkayaKG, 2021. COVID-19 diagnosis—a review of current methods. Biosens Bioelectron, 172:112752. [139]YueC, SongWL, WangL, et al., 2023. ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5. Lancet Infect Dis, 23(3):278-280. [140]YueL, XieTH, YangT, et al., 2022. A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine. J Med Virol, 94(1):35-38. [141]ZavaTT, ZavaDT, 2021. Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays. Bioanalysis, 13(1):13-28. [142]ZhangCY, ShiDM, LiXY, et al., 2022. Microfluidic electrochemical magnetoimmunosensor for ultrasensitive detection of interleukin-6 based on hybrid of AuNPs and graphene. Talanta, 240:123173. [143]ZhangYM, ZhangY, XieKB, 2020. Evaluation of CRISPR/Cas12a-based DNA detection for fast pathogen diagnosis and GMO test in rice. Mol Breed, 40:11. [144]ZhuN, ZhangDY, WangWL, et al., 2020. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 382(8):727-733. Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou
310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn Copyright © 2000 - 2024 Journal of Zhejiang University-SCIENCE |
Open peer comments: Debate/Discuss/Question/Opinion
<1>